Cover Image

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) remain a clinical challenge due to limited treatment options. Recently, cefiderocol, a novel siderophore cephalosporin, and sulbactam-durlobactam, a bactericidal β-lactam-β-lactamase inhibitor combination, ha...

Full description

Saved in:

Bibliographic Details
Main Authors:	Arta Karruli (Author), Antonella Migliaccio (Author), Spyros Pournaras (Author), Emanuele Durante-Mangoni (Author), Raffaele Zarrilli (Author)
Format:	Book
Published:	MDPI AG, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022)

In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from Italy
by: Bernardetta Segatore, et al.
Published: (2022)

Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study
by: Federica Calò, et al.
Published: (2023)

Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
by: Claudia Alteri, et al.
Published: (2024)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)

Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection Model
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022)

Cefiderocol for Severe Carbapenem-Resistant <i>A. baumannii</i> Pneumonia: Towards the Comprehension of Its Place in Therapy
by: Emanuele Rando, et al.
Published: (2021)

Monitoring Immune Dysfunction in Critically Ill Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Sepsis Treated with Regimens Including Cefiderocol: A Pilot Study to Identify Accessible Biomarkers to Stratify Patients' Prognosis
by: Antonella Frattari, et al.
Published: (2024)

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in <i>Acinetobacter baumannii</i>
by: Natalia Kolesnik-Goldmann, et al.
Published: (2023)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples
by: Davide Carcione, et al.
Published: (2021)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022)

Dynamic Gene Clusters Mediating Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates
by: Samy Selim, et al.
Published: (2022)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Filomena Sannio, et al.
Published: (2022)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Comparative Transcriptomic Profiling of Pellicle and Planktonic Cells from Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Heng Kang Ng, et al.
Published: (2023)

Bibliometric Examination of Global Scientific Research about Carbapenem-Resistant <i>Acinetobacter Baumannii</i> (CRAB)
by: Himanshu Jangid, et al.
Published: (2023)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
by: Amber DelleFave, et al.
Published: (2023)

Molecular Epidemiology of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from Northern Africa and the Middle East
by: Paul G. Higgins, et al.
Published: (2021)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Joonhyeok Choi, et al.
Published: (2021)

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established <i>Acinetobacter baumannii</i> Biofilms
by: Lois Chinwe Nwabor, et al.
Published: (2023)

Virulence of Acinetobacter baumannii Exhibiting Phenotypic Heterogeneous Growth against Meropenem in a Murine Thigh Infection Model
by: Spyros Pournaras, et al.
Published: (2013)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

Prevalence of Carbapenem Resistance Genes among <i>Acinetobacter baumannii</i> Isolated from a Teaching Hospital in Taiwan
by: Pai-Wei Su, et al.
Published: (2023)

Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Marco Merli, et al.
Published: (2023)

Phenotypic and Genotypic Investigation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Maharaj Nakhon Si Thammarat Hospital, Thailand
by: Sirijan Santajit, et al.
Published: (2023)

Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Ozioma F. Nwabor, et al.
Published: (2021)